Evaluation of Indian Gooseberry/ Amla in the Management of Chronic Periodontitis (NCT07531823) | Clinical Trial Compass
CompletedNot Applicable
Evaluation of Indian Gooseberry/ Amla in the Management of Chronic Periodontitis
India30 participantsStarted 2020-03-20
Plain-language summary
This study aimed to evaluate the influence of amla (Emblica officinalis) on patients with chronic generalized periodontitis, using a single-blind, randomized controlled study design.
1. At baseline, all participants fulfilling the I/E criteria would be randomized into Arm I or II.
2. All participants in Arm I and II would undergo scaling and root planing (SRP).
3. After 1 month, Arm I participants would receive adjunct amla for 2 weeks, and Arm II participants would receive no treatment.
4. Both arms would be followed until the end of 6 months and evaluated for clinical and biochemical parameters.
Who can participate
Age range
18 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Patients who have at least 20 remaining teeth, with chronic generalized periodontitis, as defined as \> 30 % sites involved (extent) and with moderate to severe involvement (severity) as characterized by \> 2 interproximal sites with clinical attachment loss (CAL) \> 4mm (not on the same tooth) AND/OR \> 5 mm, probing depth (not on the same tooth) AND/OR \> 2 interproximal sites with CAL \> 6 mm AND 1 interproximal site with PD \> 5mm.
. Systemically healthy patients
Exclusion criteria
. Medically compromised patients
. Smokers
. Pregnant and lactating women
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Improvement in clinical parameters (plaque index)
Timeframe: 1, 3 and 6 months
2
Improvement in clinical parameters (gingival index)
Timeframe: 1,3 and 6 months
3
Improvement in clinical parameters (bleeding index)
Timeframe: 1,3 and 6 months
4
Improvement in clinical parameters (probing pocket depth)
Timeframe: 1,3 and 6 months
5
Improvement in clinical parameters (clinical attachment level)
Timeframe: 1,3 and 6 months
Trial details
NCT IDNCT07531823
SponsorMahatma Gandhi Postgraduate Institute of Dental Sciences
. Patients who had received any antimicrobial therapy in the past 2 months, on ongoing antimicrobial therapy, or would receive antimicrobials during the course of the study.
. Patients who had undergone any periodontal surgery in the past 6 months